Patents-Review.com
🔗 Permalink
Assignee profile:

SYNTAXIN, LIMITED

City:

Abingdon

Country:

United Kingdom

Published Applications:

20

Last publication date:

2015-02-05

Patent Grants:

14

Last grant date:

2017-05-16

Top Inventors for applications by SYNTAXIN, LIMITED

These are the the leading inventors for applications assigned to SYNTAXIN, LIMITED:

Recent patent applications by SYNTAXIN, LIMITED

SYNTAXIN, LIMITED based in Abingdon, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-02-05 ✅ Patent 9,650,622 granted on 2017-05-16
US20150038401A1
Chemistry; metallurgy

Carrier for targeting nerve cells

 #2 | 2015-01-29 ✅ Patent 9,422,344 granted on 2016-08-23
US20150030584A1
Chemistry; metallurgy

Transport protein which is used to introduce chemical compounds into nerve cells

 #3 | 2014-10-09
US20140302006A1
Chemistry; metallurgy

SUPPRESSION OF NEUROENDOCRINE DISEASES

 #4 | 2014-09-25 ✅ Patent 10,113,159 granted on 2018-10-30
US20140286925A1
Chemistry; metallurgy

Suppression of cancer

 #5 | 2014-08-07 ✅ Patent 10,550,377 granted on 2020-02-04
US20140219983A1
Chemistry; metallurgy

Suppression of prostate cancer using a targeted clostridial neurotoxin

 #6 | 2014-02-27
US20140056870A1
Chemistry; metallurgy

FUSION PROTEINS

 #7 | 2013-11-28 ✅ Patent 9,115,350 granted on 2015-08-25
US20130315888A1
Chemistry; metallurgy

Carrier for targeting nerve cells

 #8 | 2013-05-09 ✅ Patent 8,956,847 granted on 2015-02-17
US20130115682A1
Chemistry; metallurgy

Fusion proteins

 #9 | 2012-09-13 ✅ Patent 9,243,301 granted on 2016-01-26
US20120230975A1
Human necessities

Fusion proteins

 #10 | 2012-07-26 ✅ Patent 9,072,736 granted on 2015-07-07
US20120189610A1
Human necessities

Treatment of pain

 #11 | 2012-06-14 ✅ Patent 8,372,615 granted on 2013-02-12
US20120149084A1
Chemistry; metallurgy

Fusion proteins

 #12 | 2012-05-24
US20120128700A1
Chemistry; metallurgy

CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS

 #13 | 2012-04-26 ✅ Patent 8,852,603 granted on 2014-10-07
US20120101027A1
Chemistry; metallurgy

Inhibition of secretion from non-neuronal cells

 #14 | 2011-06-30 ✅ Patent 8,796,216 granted on 2014-08-05
US20110160135A1
Chemistry; metallurgy

Suppression of neuroendocrine diseases

 #15 | 2011-06-30
US20110158973A1
Chemistry; metallurgy

SUPPRESSION OF CANCERS

 #16 | 2011-06-23
US20110152174A1
Chemistry; metallurgy

INHIBITION OF SECRETION FROM NON-NEURONAL CELLS

 #17 | 2011-04-21
US20110091437A1
Human necessities

FUSION PROTEINS

 #18 | 2010-01-28 ✅ Patent 8,012,491 granted on 2011-09-06
US20100022751A1
Chemistry; metallurgy

Recombinant toxin fragments

 #19 | 2009-10-01 ✅ Patent 8,454,976 granted on 2013-06-04
US20090246827A1
Chemistry; metallurgy

Recombinant toxin fragments

 #20 | 2006-03-09 ✅ Patent 8,158,132 granted on 2012-04-17
US20060051356A1
Chemistry; metallurgy

Clostridial toxin derivatives able to modify peripheral sensory afferent functions
AssigneeID:

21758 ⎘